Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Ostomy Care01:24

Ostomy Care

Introduction
An ostomy is a surgical procedure that creates an artificial opening from the intestines to the outside of the body, allowing for the rerouting of effluent. This opening is known as a stoma. A stoma usually protrudes above the skin surface, appearing pink or red, moist, and round, and it lacks nerve sensations.
There are different types of ostomies, including colostomies, ileostomies, and urostomies:
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omic analysis reveals brain-blood concordance and persistent neuroimmune reprogramming with stress and toxicant exposure in a mouse model of Gulf War Illness.

Brain, behavior, & immunity - health·2026
Same author

Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat.

Neuroscience·2010
Same author

Inflammasomes bridge signaling between pathogen identification and the immune response.

Drugs of today (Barcelona, Spain : 1998)·2009
Same author

CXCL13 expression in Chlamydia trachomatis infection of the female reproductive tract.

Drugs of today (Barcelona, Spain : 1998)·2009
Same author

Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats.

Experimental brain research·2009
Same author

Bile acid absorption after near-total proctocolectomy in dogs: ileal pouch vs. jejunal pouch-distal rectal anastomosis.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2002
Same journal

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

Gut·2026
Same journal

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Gut·2026
Same journal

USP20 promotes CD8<sup>+</sup> T cell exhaustion and impairs KRAS<sup>G12D</sup> inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer.

Gut·2026
Same journal

CTCF-rs705704-SUOX axis is important for the association between hypothyroidism and metabolic dysfunction-associated steatotic liver disease.

Gut·2026
Same journal

<i>Helicobacter pylori</i> infection, treatment and colorectal cancer risk by genetic predisposition: evidence from two randomised trials.

Gut·2026
Same journal

Correction: Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.

Gut·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Diarrhoea after continent ileostomy

D G Kelley, M E Branon, S F Phillips

    Gut
    |August 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Approximately 30% of patients with continent ileostomies experience malabsorption, including excessive fecal losses and decreased vitamin B12 uptake. This contrasts with conventional ileostomies, indicating potential complications of ileal pouch surgery.

    More Related Videos

    Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
    08:20

    Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

    Published on: July 12, 2018

    A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
    04:05

    A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

    Published on: May 31, 2024

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
    07:06

    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

    Published on: December 8, 2014

    Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
    08:20

    Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

    Published on: July 12, 2018

    A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
    04:05

    A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

    Published on: May 31, 2024

    Area of Science:

    • Gastroenterology
    • Surgical Outcomes
    • Nutritional Science

    Background:

    • Continent ileostomies, particularly ileal pouches, are surgical alternatives to conventional ileostomies.
    • Assessing the long-term functional outcomes and potential complications of ileal pouches is crucial for patient management.

    Purpose of the Study:

    • To investigate the prevalence and characteristics of malabsorption in patients with continent ileostomies.
    • To compare malabsorptive parameters between patients with ileal pouches and those with conventional ileostomies.

    Main Methods:

    • Faecal and urine analyses were conducted on 42 patients with ileal pouches and 19 patients with conventional ileostomies.
    • Patients with conventional ileostomies were matched to those with ileal pouches for comparison.

    Main Results:

    • Approximately 30% of patients with continent ileostomies exhibited excessive faecal volumes.
    • These patients showed increased faecal losses of electrolytes, nitrogen, and fat, alongside reduced vitamin B12 absorption.
    • The remaining patients with continent ileostomies had comparable outputs to those with conventional ileostomies.

    Conclusions:

    • Malabsorption is a significant complication affecting a notable proportion of patients with continent ileostomies.
    • Ileal pouch surgery may be associated with specific malabsorptive issues, necessitating monitoring and management.
    • Further research is warranted to elucidate the mechanisms and optimize interventions for malabsorption in this patient group.